Today’s Short Interest Alert: Casualty Medical Systems Incorporated (NASDAQ:CASM)’s Stock Is Buy After Less Market Selling

November 28, 2016 - By Winifred Garcia   ·   0 Comments

Today's Short Interest Alert: Casualty Medical Systems Incorporated (NASDAQ:CASM)'s Stock Is Buy After Less Market Selling

The stock of Casualty Medical Systems Incorporated (NASDAQ:CASM) registered a decrease of 12.79% in short interest. CASM’s total short interest was 49,100 shares in November as published by FINRA. Its down 12.79% from 56,300 shares, reported previously. With 18,100 shares average volume, it will take short sellers 3 days to cover their CASM’s short positions. The short interest to Casualty Medical Systems Incorporated’s float is 0.69%. About 2,566 shares traded hands. CAS Medical Systems Inc (NASDAQ:CASM) has declined 10.77% since April 25, 2016 and is downtrending. It has underperformed by 16.78% the S&P500.

CAS Medical Systems, Inc. is a medical technology firm that develops, makes and markets non-invasive patient monitoring products for patient care. The company has a market cap of $47.45 million. The Firm designs, makes and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It currently has negative earnings. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales.

Insitutional Activity: The institutional sentiment decreased to 0.56 in 2016 Q2. Its down 0.58, from 1.14 in 2016Q1. The ratio fall, as 3 funds sold all CAS Medical Systems Inc shares owned while 4 reduced positions. 3 funds bought stakes while 5 increased positions. They now own 8.79 million shares or 11.09% less from 9.89 million shares in 2016Q1.
Guggenheim Limited, a Illinois-based fund reported 12,711 shares. Wells Fargo & Mn holds 0% of its portfolio in CAS Medical Systems Inc (NASDAQ:CASM) for 2,250 shares. Penbrook Management Lc last reported 0.09% of its portfolio in the stock. 1492 Cap Mgmt Limited Liability last reported 71,944 shares in the company. Bank Of America De accumulated 16 shares or 0% of the stock. Manufacturers Life The, a Ontario – Canada-based fund reported 5,285 shares. Acuta Lc accumulated 3.1% or 3.50 million shares. Vanguard Gp Inc, a Pennsylvania-based fund reported 507,732 shares. Tower (Trc) last reported 0% of its portfolio in the stock. Blackrock Fund Advsr last reported 97,649 shares in the company. Deutsche Financial Bank Ag last reported 37,535 shares in the company. Td Mgmt Ltd Com has invested 0.02% of its portfolio in CAS Medical Systems Inc (NASDAQ:CASM). California Public Employees Retirement System has 0% invested in the company for 10,400 shares. Moreover, Kcg Holdings Incorporated has 0% invested in CAS Medical Systems Inc (NASDAQ:CASM) for 32,840 shares. Deerfield Management accumulated 0.23% or 3.20M shares.

CASM Company Profile

CAS Medical Systems, Inc., incorporated on December 5, 1984, is a medical technology firm that develops, makes and markets non-invasive patient monitoring products for patient care. The Firm designs, makes and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. The Firm also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales. The Firm operates through two categories of sales: Tissue Oximetry Monitoring and Traditional Monitoring. Tissue Oximetry Monitoring includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories. Traditional Monitoring includes sales of the Company’s legacy products comprising the original equipment maker (OEM) sales of its non-invasive blood pressure technology (MAXNIBP and MAXIQ), and monitor service and repair.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Winifred Garcia

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>